HIF1α is one of key transcription factors which enhanced glycolytic genes transcription (Semenza, 2010); finding the mediator who regulating HIF1α‐related glycolysis is important for exploiting effective and targeted therapies for cancer. The gene discussed is HIF1A; the disease is cancer.